Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012))

Fei Su; Xiaoping Wang; Troy Pearson; Jangsoon Lee; Savitri Krishnamurthy; Naoto T. Ueno; Mikhail G. Kolonin

doi:10.1016/j.omto.2022.05.007

Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012))

Fei Su, Xiaoping Wang, Troy Pearson, Jangsoon Lee, Savitri Krishnamurthy, Naoto T. Ueno, Mikhail G. Kolonin

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

(Molecular Therapy: Oncolytics 18, 579–586; September 2020) In the originally published version of this article, Figure 1D had “MCF7 / mammary ASC” image inadvertently included from “MCF7 / SAT ASC” group. In the corrected Figure 1, MCF7 data are replaced from an independent experiment, which showed the same results as originally published. Figure 1E is correspondingly updated with new MCF7 graph bars based on new Figure 1D. The authors regret this error.[Formula

Original language	English (US)
Pages (from-to)	305-306
Number of pages	2
Journal	Molecular Therapy Oncolytics
Volume	25
DOIs	https://doi.org/10.1016/j.omto.2022.05.007
State	Published - Jun 16 2022

ASJC Scopus subject areas

Molecular Medicine
Oncology
Cancer Research
Pharmacology (medical)

Access to Document

10.1016/j.omto.2022.05.007

Fingerprint

Dive into the research topics of 'Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012))'. Together they form a unique fingerprint.

Cite this

Su, F., Wang, X., Pearson, T., Lee, J., Krishnamurthy, S., Ueno, N. T., & Kolonin, M. G. (2022). Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012)). Molecular Therapy Oncolytics, 25, 305-306. https://doi.org/10.1016/j.omto.2022.05.007

Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012)). / Su, Fei; Wang, Xiaoping; Pearson, Troy et al.
In: Molecular Therapy Oncolytics, Vol. 25, 16.06.2022, p. 305-306.

Research output: Contribution to journal › Comment/debate › peer-review

Su, F, Wang, X, Pearson, T, Lee, J, Krishnamurthy, S, Ueno, NT & Kolonin, MG 2022, 'Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012))', Molecular Therapy Oncolytics, vol. 25, pp. 305-306. https://doi.org/10.1016/j.omto.2022.05.007

Su F, Wang X, Pearson T, Lee J, Krishnamurthy S, Ueno NT et al. Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012)). Molecular Therapy Oncolytics. 2022 Jun 16;25:305-306. doi: 10.1016/j.omto.2022.05.007

@article{7ed609efffce4a4e8e6f650e64c69b3f,

title = "Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012))",

abstract = "(Molecular Therapy: Oncolytics 18, 579–586; September 2020) In the originally published version of this article, Figure 1D had “MCF7 / mammary ASC” image inadvertently included from “MCF7 / SAT ASC” group. In the corrected Figure 1, MCF7 data are replaced from an independent experiment, which showed the same results as originally published. Figure 1E is correspondingly updated with new MCF7 graph bars based on new Figure 1D. The authors regret this error.[Formula",

author = "Fei Su and Xiaoping Wang and Troy Pearson and Jangsoon Lee and Savitri Krishnamurthy and Ueno, {Naoto T.} and Kolonin, {Mikhail G.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s)",

year = "2022",

month = jun,

day = "16",

doi = "10.1016/j.omto.2022.05.007",

language = "English (US)",

volume = "25",

pages = "305--306",

journal = "Molecular Therapy Oncolytics",

issn = "2372-7705",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Erratum

T2 - Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012))

AU - Su, Fei

AU - Wang, Xiaoping

AU - Pearson, Troy

AU - Lee, Jangsoon

AU - Krishnamurthy, Savitri

AU - Ueno, Naoto T.

AU - Kolonin, Mikhail G.

PY - 2022/6/16

Y1 - 2022/6/16

N2 - (Molecular Therapy: Oncolytics 18, 579–586; September 2020) In the originally published version of this article, Figure 1D had “MCF7 / mammary ASC” image inadvertently included from “MCF7 / SAT ASC” group. In the corrected Figure 1, MCF7 data are replaced from an independent experiment, which showed the same results as originally published. Figure 1E is correspondingly updated with new MCF7 graph bars based on new Figure 1D. The authors regret this error.[Formula

AB - (Molecular Therapy: Oncolytics 18, 579–586; September 2020) In the originally published version of this article, Figure 1D had “MCF7 / mammary ASC” image inadvertently included from “MCF7 / SAT ASC” group. In the corrected Figure 1, MCF7 data are replaced from an independent experiment, which showed the same results as originally published. Figure 1E is correspondingly updated with new MCF7 graph bars based on new Figure 1D. The authors regret this error.[Formula

UR - http://www.scopus.com/inward/record.url?scp=85136252096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136252096&partnerID=8YFLogxK

U2 - 10.1016/j.omto.2022.05.007

DO - 10.1016/j.omto.2022.05.007

M3 - Comment/debate

C2 - 35663226

AN - SCOPUS:85136252096

SN - 2372-7705

VL - 25

SP - 305

EP - 306

JO - Molecular Therapy Oncolytics

JF - Molecular Therapy Oncolytics

ER -

Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this